• WELCOME TO
    AVANTGARDE UROLOGY
    Center of Minimally Invasive Surgery

Published Abstracts

  • 1. UBC RAPID TEST and urothelium carcinoma.
    K. Milathianakis, I. Mpogdanos, D. Karamanolakis, I. Gavriel, A. Tsintavis.
    PUBLISHED ABSTRACT No: O31 to the VIMA OF CLINICAL ONCOLOGY Vol. 4 – Supplement 2001, pp: 126.

  • 2. Hematologic response and improvement of the quality of life, in patients with chronic anemia of the prostate cancer treated with recombinant human erythropoietin.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, A. Chloraki-Mpompota, M. Spyropoulou, D. Sirseloudis, P. Repousis, E. Pagkalou-Thoua, A. Tsintavis.
    PUBLISHED ABSTRACT: Haema Vol.4, No 5-Supplement (1) 2001, p 368.

  • 3. Ureteropelvic junction obstruction due to crossing renal vessels: clinical and imaging features.
    A.Rigas, D. Karamanolakis, Ch. Mamoulakis, A. Stefanidis, P.A.  Androulakakis.
    PUBLISHED ABSTRACT in British Journal of Urology International, official Journal of the ESPU.

  • 4. Comparative study between the cytologic examination of the urine speciment and the BTA-stat test for bladder cancer.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, S. Plyta, A. Pannoussi, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.
    PUBLISHED ABSTRACT No: P 85: VIMA OF CLINICAL ONCOLOGY, Vol. 5 - Supplement 2002, p 178.

  • 5. Treatment of the prostate cancer related anemia in patients with hormone refractory PCa and bone metastases using Epoetin-B.
    D. Karamanolakis, I. Mpogdanos, D. Syrseloudis, G. Kourti, P. Repoussis, A.    Chloraki-Bobota, K. Milathianakis, H. Matzed, E. Paghalou-Thoua, A. Tsintavis.
    PUBLISHED ABSTRACT No: P 89: VIMA OF CLINICAL ONCOLOGY, Vol.5 - Supplement 2002, pp: 180.

  • 6. Effect of Aminofostine on toxicities associated with radiation therapy for localized prostate cancer.
    M. Synodinou-Menegaki, D. Antonadou, M. Bouphy, D. Karamanolakis, N. Biazis, K. Papatheodorou, D. Nikolakis, K. Milathianakis, N. Trouvalas.
    PUBLISHED ABSTRACT, No: P , in the relative suppl. of Journal of   European Society of Radiology and Oncology, Vol. 64, Supplement 1, September 2002, p:. Official Journal of the ESTRO.

  • 7. Radiotherapy for elderly patients with locally advanced bladder cancer supported with aminofostine.
    M. Bouphy, M. Synodinou-Menegaki, D. Antonadou, I. Mpogdanos, D. Karamanolakis, K. Milathianakis, M. Hristodoulidou, G. Sarris, N. Throuvalas.
    PUBLISHED ABSTRACT, No: P 1046, in the relative suppl. of Journal of European Society of Radiology and Oncology, Vol. 64, Supplement 1, September 2002, pp: 306. Official Journal of the ESTRO.

  • 8. Penile metastases of transitional cell carcinoma of the bladder presenting as priapism. Report of two cases [Moderated Poster. Published abstract].
    D.K. Karamanolakis, K.N. Milathianakis, I.M. Mpogdanos, I. Michailidis, G.D. Becchini, M. Synodinou.
    PUBLISHED ABSTRACT, No: MP-3.4.12, British Journal of Urology International Vol 90- Supplement 2, September 2002, p: 113. Official Journal of SIU.

  • 9. Anemia associated with Hormone Refractory Prostate Carcinoma. Effects of Recombinant Human Epoietin-B [Moderated Poster. Published abstract].
    D.K. Karamanolakis, K.N. Milathianakis, I.M. Mpogdanos, P.B. Repousis, A. Chloraki-Bobota, H. Majed, E. Pagalou-Thoua, A.H. Tsintavis.
    PUBLISHED ABSTRACT, No: MP-5.1.10, British Journal of Urology International Vol 90- Supplement 2, September 2002, p: 181. Official Journal of SIU.

  • 10. How useful Octreoscan is in hormone-refractory prostate cancer patients with osseous metastases.
    M. Koutsilieris, K. Milathianakis, J. Bogdanos, D. Karamanolakis, A. Stavraka, G.S. Limouris.
    PUBLISHED ANSTRACT in European Journal of Nuclear Medicine and Molecular Imaging, Abstract No: P 198, Vol 29, Supplement 1, August 2002, p:240. Official Journal of the European Association of Nuclear Medicine.

  • 11. Quality of life in patients with superficial bladder cancer under BCG treatment.
    K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: O 303) [www.iatrotek.org].

  • 12. Casually detected prostate adenocarcinoma in radical cystectomies’ specimens for invasive bladder carcinoma.
    K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces  (Abstract No: P 410) [www.iatrotek.org].

  • 13. The application of flowcytometric methods in the evaluation of transitional cell carcinoma tumors of the bladder.
    Alexia S, K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: P 411) [www.iatrotek.org].

  • 14. Treatment of BCG instillation induced hematuria with the intravescical somministration of GM-CSF growth factor.
    DK. Karamanolakis, I. Bogdanos, K. Milathianakis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: P 409) [www.iatrotek.org].

  • 15. Treatment of painful bone metastases in patients with hormone-refractory prostate cancer with the administration of Zolendronic acid.
    Mpogdanos J, Karamanolakis D, Milathianakis K, Tsintavis A, Koutsilieris M.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: P 412) [www.iatrotek.org].

  • 16. Correlation between the detection of positive endoprostatic surgical margins and disease progression.
    K. Milathianakis, I. Bogdanos, DK. Karamanolakis, G. Vecchini, A. Tsintavis, P. Arapantoni-Dadioti.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: O 309) [www.iatrotek.org].

  • 17. Influence of Combined Androgen Blockade in bone density in patients with locally advanced prostate cancer.
    I. Bogdanos, DK. Karamanolakis, K. Milathianakis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: O 308) [www.iatrotek.org].

  • 18. Comparative study of the diagnostic capacity of the cytologic examination of the urine specimen and BTA stat-test in transitional cell carcinomas.
    DK. Karamanolakis, I. Bogdanos, K. Milathianakis, A. Tsintavis, A. Panousi, S. Plyta, A. Alexiadou, E. Poulianou-Kyprioti.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: O 302) [www.iatrotek.org].

  • 19. The use of Zolendronic acid in painful osseous metastases due to prostate cancer. (Moderated Poster)
    Milathianakis C., Bogdanos J, Karamanolakis K D, Tsintavis A, Koutsilieris M.
    PUBLISHED ABSTRACT, Abstract No: MP 747, European Urology Vol. 2, Supplement 1, February 2003, p: 189. Official Journal of the EAU.

  • 20. Myogenic bladder decompensation in boys with a history of posterior urethral valves is caused by secondary bladder neck dysfunction?
    Dimitrios K. Karamanolakis, Georgios Tsahouridis, Antonios A. Stefanidis,   Philippos A. Androulakakis. [Moderated Poster].
    PUBLISHED ABSTRACT Volume 93, Issue 52, p64, British Journal of Urology International, Official Journal of ESPU.

  • 21. Acceptabilité et evolution de l’incontinentation prothetique par protheses Memocath.
    Ruffion A, Karamanolakis D, Leriche A.
    PUBLISHED ABSTRACT Volume 14, Issue 5, Supplement 1, p5A, Progrès en Urologie, Official Journal of AFU.

  • 22. Evaluation de l’ echographie protable sur 100 patients en consultation d’ Urologie.
    Devonec M, Ruffion A, Lopez JG, Champetier D, Roumier X, Hoch M, Tajjour M, Karamanolakis D, Perrin P.
    PUBLISHED ABSTRACT Volume 14, Issue 5, Supplement 1, p13A, Progrès en Urologie, Official Journal of AFU.

  • 23. L’ IPSS peut-il être remplacé par une echelle analogique visuelle?
    Perrin P, Cucherat M, Karamanolakis D, Ruffion A.
    PUBLISHED ABSTRACT Volume 14, Issue 5, Supplement 1, p63A, Progrès en Urologie, Official Journal of AFU.

  • 24. "What is the optimal dose of botulinum toxin a disport in neurogenic detrusor overactivity? A dose-effect study.
    A. Ruffion [1], Y. Tanneau [2], A. Gignoux [1], S. Culem [1], D.Karamanolakis [1], B. Leriche [1], A. Leriche [1], P. Grise [2]
    [1] Centre Hospitalier Lyon Sud, Service Urologie, Lyon, France, [2]Centre Hospitalier Charles Nicolle, Service Urologie, Rouens, France.
    PUBLISHED ABSTRACT Volume, Issue, Supplement 2005, p, European    Urology, Official Journal of EAU.

  • 25. Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs zoledronate in patients with androgen ablation refractory prostate cancer. (moderated poster) CME: 5
    Koutsilieris M, Mitsiades C, Bogdanos J, Karamanolakis D, Milathianakis C, Sourla A, Dimopoulos T.
    PUBLISHED ABSTRACT Volume 5, Issue 2, Supplement 2006, p93, European    Urology, Official Journal of EAU.

  • 26. Laparoscopic transvesical adenomectomy for BPH in massive prostate glands.
    Dimitrios K Karamanolakis, Gordon Kooiman, Rajbabu Krishnamoorthy, Peter M. Thompson, Gordon Muir, H. Godbele, Philippe Grange.
    PUBLISHED ABSTRACT Volume 20, Supplement 1, 2006, p.272, Journal of Endourology, Official Journal of EndoUrological Society.

  • 27. Measurement of serum testosterone as potentially adjunct screening test for the assessment of the risk for prostate cancer among men with PSA values >,3.0 ng/ml and ≤ 10.0 ng/ml.
    D. Karamanolakis, T. Lambou, J. Bogdanos, C. Milathianakis, A. Sourla, P. Lembessis, A. Halapas, N. Pissimissis, N. Dessypris, E. Petridou, M. Koutsilieris.
    PUBLISHED ABSTRACT Vol , Issue 2006, p: of European Urology Supplements, Official Journal of EAU.

  • 28. Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs zoledronate in patients with androgen ablation refractory prostate cancer.
    Koutsilieris M, Mitsiades C, Bogdanos J, Karamanolakis D, Milathianakis C, Sourla A, Dimopoulos T.    
    PUBLISHED ABSTRACT Vol , Issue 2006, p: of European Urology Supplements, Official Journal of EAU.

  • 29. Laparoscopic partial nephrectomy, no clamp no suture technique.
    Lam W, Kouriefs C, Sharma DM, Arya M, Karamanolakis D, Kooiman G, Grange P.
    PUBLISHED ABSTRACT Vol 8(4), Issue 2009, p 129: of European Urology Supplements, Official Journal of EAU.

  • 30. Measurement of serum testosterone as potentially adjunct screening test for the assessment of the risk of prostate cancer amongst men with PSA values ?3.0 and <,10ng/ml.
    DK Karamanolakis, Th. Lambou, J. Bogdanos, C. Milathianakis, A. Sourla, P. Lembessis, A. Halapas, N. Pissimissis, N. Desypris, E. Petridou, M. Koutsilieris.
    PUBLISHED ABSTRACT Vol 6 No 3 pp229-275 Abstract 49 (p240)Journal of Men’s Health

  • 31. Measurement of serum testosterone as potentially adjunct screening test for the assessment of the risk of prostate cancer amongst men with PSA values ?3.0 and <,10ng/ml.
    DK Karamanolakis, Th. Lambou, J. Bogdanos, C. Milathianakis, A. Sourla, P. Lembessis, A. Halapas, N. Pissimissis, N. Desypris, E. Petridou, M. Koutsilieris. (Moderated Poster).

  • 32. 3Dimentional pathological mapping biopsies of the prostate: our initial experience.
    DK Karamanolakis, S. Pomplun.
Attention! The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your physician for further evaluation.

Send your reply